Search results
Found 6 matches for
The collective force of cancer research, outreach and care across the city of Oxford, translating discoveries into better care for cancer patients.
Vaccine for treating cancer made possible using Oxford COVID vaccine technology
3 September 2021
A new publication from Benoit Van den Eynde's group has shown that a viral vector cancer vaccine generates effective anti-tumour immune responses and, in combination with immunotherapy, decreases tumour size and increases survival rates in mouse models.
T-cell landscape mapping identifies new targets for pancreatic cancer immunotherapy
13 April 2021
Through analysis of T-cell populations, Oxford pancreatic researchers identify novel therapeutic opportunities in pancreatic cancer patients
Improving immunotherapy through epigenetics
12 March 2021
Professor Yang Shi’s group uses combination therapy to eradicate tumours that previously responded poorly to immunotherapy
Christina Ye awarded CRUK pre-doctoral fellowship
11 February 2021
Christina Ye has been awarded CRUK pre-doctoral fellowship, she tells us about her upcoming project into T cell trafficking between the blood and skin when patients undergo checkpoint immunotherapy
What we can learn from cancer survivors
- Checkpoint Therapy
- Collaboration
- Drug Discovery
- Immunology
- Immunotherapy
- Pancreatic Cancer
- Pancreatic Cancer Awareness Month
- Treatment
19 November 2020
Understanding how an individual survives cancer, and why they respond well to therapy, can be vital in identifying new therapeutic targets. A new project seeks to see why some advanced pancreatic cancer patients overcome the odds and respond positively to treatment.
Epigenetic markers for melanoma patient response to ICB therapy
3 September 2020
Development fund winners Rosalin Cooper & Ben Fairfax are investigating the epigenetic landscape of melanoma patients and how it can impact patient sensitivity to ICB therapy